Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva swings to profit; adjusted net up 18%
Marketwatch
Tuesday, February 16, 2010 - 9:32am
tags:
Teva Pharmaceuticals, earnings
China Biotech Week in Review
Seeking Alpha
Tuesday, February 16, 2010 - 9:30am
tags:
China, 3SBio, NeoStem, Simcere, Tianyin Pharmaceutical, Celsis In Vitro
Teva and Novartis reach settlement on Famvir suit
Marketwatch
Tuesday, February 16, 2010 - 9:29am
tags:
Teva Pharmaceuticals, Novartis, lawsuits, settlements, Famvir
Analysts: Effient won't be a blockbuster
Fierce Pharma
Tuesday, February 16, 2010 - 9:28am
tags:
Effient, blood thinners, Eli Lilly
Pharmas Walking the Patent Tightrope
Seeking Alpha
Tuesday, February 16, 2010 - 9:26am
tags:
Alzheimer's disease, Teva Pharmaceuticals, Janssen Pharmaceuticals, Eli Lilly, patents, Actavis
AstraZeneca Gets a Healthy Shot With Crestor
Seeking Alpha
Tuesday, February 16, 2010 - 9:25am
tags:
AstraZeneca, Crestor, statins, Pfizer
Cell Therapeutics Still Waiting on Its Diagnosis
Seeking Alpha
Tuesday, February 16, 2010 - 9:23am
tags:
Cell Therapeutics, pixantrone, Novartis
Takeda announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix
PR-Canada.net
Saturday, February 13, 2010 - 12:22pm
tags:
Takeda, PPIs, Plavix
AstraZeneca reassures investors on earnings
The News Journal
Saturday, February 13, 2010 - 11:34am
tags:
AstraZeneca
QIAGEN and Celera Establish Distribution Agreement for Respiratory Pathogen Panel
PR-USA.net
Saturday, February 13, 2010 - 11:33am
tags:
Qiagen, Celra
Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy, T-Cell Vaccine
Medical News Today
Saturday, February 13, 2010 - 11:31am
tags:
Circassia, Ragweed Allergy, vaccines
Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Medical News Today
Saturday, February 13, 2010 - 11:30am
tags:
stem cells, leukemia, lymphoma, StemEx
US patent for Avanir Pharma's low-dose quinidine formulations of Zeniva
Pharmabiz
Saturday, February 13, 2010 - 11:28am
tags:
Avanir, Zenvia
Perrigo Wins Patent Suit on Mucinex
WHTC.com
Saturday, February 13, 2010 - 11:24am
tags:
Perrigo Company, Mucinex, Adams Respiratory Therapeutics
Gardens drug start-up finds success in Canada with safe-dosing device
Palm Beach Post, FL
Saturday, February 13, 2010 - 11:21am
tags:
AccuDial
As Labopharm Prepares for Oleptro Launch, it Seeks $20M
insurancenewsnet.com
Saturday, February 13, 2010 - 11:19am
tags:
Labopharm, Oleptro, depression, antidepressant
Lilly Pressured as Its First New Drug in 4 Years Falters
NY Times
Saturday, February 13, 2010 - 11:17am
tags:
Eli Lilly, Effient
Drug Industry Signals Lobbying Shift
WSJ
Saturday, February 13, 2010 - 11:14am
tags:
PhRMA, lobbying
Don't Ignore This Potential Blockbuster (taspoglutide; Roche)
The Motley Fool
Saturday, February 13, 2010 - 11:12am
tags:
taspoglutide, Roche, diabetes, Byetta, Januvia, Lantus
Alcon Profit Rises as Novartis Takeover Looms
NY Times, NY
Saturday, February 13, 2010 - 11:10am
tags:
Alcon, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.